← Eichor
Condition: Hyperchylomicronemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hyperchylomicronemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
NA · 1 location(s) · Université de Sherbrooke · NCT04227678A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants
Phase 3 · 1 location(s) · Ionis Pharmaceuticals, Inc. · NCT07727538CS-121 APOC3 Base Editing in Children and Adolescents With Hyperchylomicronemia
EARLY_Phase 1 · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT07371767CS-121 APOC3 Base Editing in FCS
EARLY_Phase 1 · 1 location(s) · CorrectSequence Therapeutics Co., Ltd · NCT07176923
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.